Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moringa vs NaOCl in Primary Molar Pulpectomy
NCT06971055Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jul 2025
- Primary completion
- Sep 2025
- Modality
- PE (Plant Extract), Dietary Supplement
- Countries
- 1
01
Overview
Randomised, single-blind trial of moringa oleifera in pulp necrosis and Endodontic infection (2 arms), sponsored by Cairo University. Primary endpoint: Zone of inhibition against Coagulase-Negative Staphylococci at Day 1. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
moringa oleifera
03
Conditions
pulp necrosisEndodontic infection
Beyond the preview
Go deeper on NCT06971055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06971055.